Safeguard Scientifics Announces Zipnosis Exit
Safeguard Scientifics, Inc. (NYSE:SFE) announced the divestiture of its ownership interest in Zipnosis for $3.3 million in initial cash and a preferred equity stake in Bright Health Group. The transaction reflects Safeguard's strategic focus on maximizing shareholder value through monetization. It signifies a gain for Safeguard for the quarter ended March 31, 2021. Since December 2015, Safeguard invested a total of $10 million into Zipnosis. CEO Eric Salzman expressed optimism about Bright Health's potential and congratulated Zipnosis on its milestone achievement.
- Received $3.3 million in initial cash proceeds from the Zipnosis divestiture.
- Acquired a preferred equity interest in Bright Health Group, positioning Safeguard for potential growth.
- Expected gain from the sale for Q1 2021, enhancing financial performance.
- None.
RADNOR, Pa., April 12, 2021 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NYSE:SFE) (“Safeguard” or the “Company”) today announced the exit of our ownership interest in Zipnosis. Safeguard received
“We are excited about this transaction and the prospects for Safeguard of being a Bright Health shareholder. We also want to congratulate Zipnosis’ Founder and CEO, Jon Pearce, and all of the Zipnosis employees on achieving this milestone. We wish them the best of luck as part of the Bright Health team,” commented Safeguard CEO Eric Salzman.
Safeguard deployed an aggregate of
About Safeguard Scientifics
Historically, Safeguard Scientifics has provided capital and relevant expertise to fuel the growth of technology-driven businesses. Safeguard has a distinguished track record of fostering innovation and building market leaders that spans more than six decades. Safeguard is currently pursuing a focused strategy to value-maximize and monetize its ownership interests over a multi-year time frame to drive shareholder value. For more information, please visit www.safeguard.com.
About Bright Health Group
Bright Health Group is building the national, integrated healthcare system of the future by integrating financing, care delivery services and technology to create a better performing healthcare experience for physicians and consumers. As a national integrated healthcare platform, we offer diversified health products and managed care services to over 500,000 consumers in 14 states and more than 50 markets. By aligning with our Care Partners, we provide consumers access to personalized care teams tailored to their individual needs. We deliver high quality virtual and in-person clinical care to over 220,000 patients through our approximately 40 managed and affiliated advanced risk-bearing primary care clinics. We give providers the tools they need to optimize their practices and deliver valued-based care to the patients they serve. Driving it all is our person-centric, intelligent technology platform which connects consumers, payers and providers with the common purpose of lowering healthcare costs while improving outcomes, experience and access. We are making healthcare right. Together. Learn more at www.brighthealthgroup.com.
Forward-looking Statements
Except for the historical information and discussions contained herein, statements contained in this release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Our forward-looking statements are subject to risks and uncertainties. Forward-looking statements include, but are not limited to, statements regarding Safeguard’s ability to maximize the value of monetization opportunities of its ownership interests and drive total shareholder returns. Safeguard’s initiatives taken or contemplated to enhance and unlock value for all of its shareholders, Safeguard’s efforts to execute on and implement its strategy to streamline its organizational structure, reduce its operating costs, pursue monetization opportunities for ownership interests and maximize the return of value to its shareholders, Safeguard’s ability to create, unlock, enhance and maximize shareholder value, the effect of Safeguard’s management succession plan on driving increased organizational effectiveness and efficiencies, the ability of the management team to execute Safeguard’s strategy, the availability of, the timing of, and the proceeds that may ultimately be derived from the monetization of ownership interests, Safeguard’s projections regarding the reduction in its ongoing operating expenses, Safeguard’s projections regarding annualized operating expenses and expected severance expenses, monetization opportunities for ownership interests, and the amount of net proceeds from the monetization of ownership interests that will enable the return of value to Safeguard shareholders after satisfying working capital needs and the timing of such return of value. Such forward-looking statements are not guarantees of future operational or financial performance and are based on current expectations that involve a number of uncertainties, risks and assumptions that are difficult to predict. Therefore, actual outcomes and/or results may differ materially from those expressed or implied by such forward-looking statements. The risks and uncertainties that could cause actual results to differ materially include, among others, our ability to make good decisions about the monetization of our ownership interests for maximum value or at all and the return of value to our shareholders, our ability to successfully execute on our strategy to streamline our organizational structure and align our cost structure to increase shareholder value, whether our strategy will better position us to focus our resources on the highest-return opportunities and deliver enhanced shareholder value, the ongoing support of our existing ownership interests, the fact that our companies may vary from period to period, challenges to achieving liquidity from our ownership interests, fluctuations in the market prices of our publicly traded holdings, if any, competition, our inability to obtain maximum value for our ownership interests, our ability to attract and retain qualified employees, market valuations in sectors in which our ownership interests operate, our inability to control our ownership interests, our need to manage our assets to avoid registration under the Investment Company Act of 1940, risks, disruption, costs and uncertainty caused by or related to the actions of activist shareholders, including that if individuals are elected to our Board with a specific agenda, it may adversely affect our ability to effectively implement our business strategy and create value for our shareholders and perceived uncertainties as to our future direction as a result of potential changes to the composition of our Board may lead to the perception of a change in the direction of our business, instability or a lack of continuity that may adversely affect our business, and risks associated with our ownership interests, including the fact that most of our ownership interests have a limited operating history and a history of operating losses, face intense competition and may never be profitable, the effect of economic conditions in the business sectors in which Safeguard’s companies operate, and other uncertainties described in our filings with the Securities and Exchange Commission. Many of these factors are beyond the Company’s ability to predict or control. As a result of these and other factors, the Company’s past operational and financial performance should not be relied on as an indication of future performance. The Company does not assume any obligation to update any forward-looking statements or other information contained in this press release.
###
FAQ
What are the details of Safeguard Scientifics' recent divestiture of Zipnosis?
How much did Safeguard invest in Zipnosis since December 2015?
What financial impact does the sale of Zipnosis have on Safeguard Scientifics?
What is the significance of the preferred equity interest in Bright Health Group for Safeguard Scientifics?
